
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Historical Deciles for [ABBV] AbbVie, Inc.
Data updated 2025-Apr-04 (Friday)Compare current performance/technical metrics to history for AbbVie, Inc.. Range of values presented below in deciles puts current values into historical context (Up to 5-years)
Provided As-is for informational/educational purposes only and should not be construed as investment advice . Past performance may not be not indicative of future results. Always consult your Investment Adviser before any decision
Share
Use widget to view Historical Metric Deciles for other Stocks/ETFs/Indices
Summary 2025-Apr-04 Friday
Day Change | -7.28% Low | Day Volatility | 7.43% Top |
Streak | ↓ 4 days Low | % Streak | -10.77% Low |
RSI | 29 Low | CCI | -245.0 Low |
MACD | -2.44 Low | ATR | 6.09 Top |
ADX | 27.5 Mid | SSO | 40.6 Mid |
Change | Volatility | % off SMA | |
---|---|---|---|
5-day | -8.93% Low | 13.95% Top | -7.41% Low |
10-day | -10.98% Low | 13.95% Top | -7.87% Low |
20-day | -12.75% Low | 17.45% Top | -10.06% Low |
50-day | +9.54% Mid | 29.19% Top | -6.60% Low |
100-day | -6.76% Low | 33.48% Mid | -0.50% Mid |
200-day | +10.18% Mid | 33.72% Mid | -0.41% Low |
Choose Metric type
Select Performance timeframe above to analyze
On 2025-Apr-04, AbbVie, Inc. had:daily change of -7.28% intraday volatility of 7.4% 4 ↓ (down) day streak yielding -10.77% See how this compares to historical ranges below. Upto last 5 years are bucketed into deciles (click on chart line for details) with 2025-Apr-04 value annotated for comparison
Related to AbbVie, Inc.
Information for AbbVie, Inc.
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Dividend History : History of Dividend Yield
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets Currently Viewing
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-May-02 on Google
SEC Reports : Quarterly reports around 2025-May-02 on SEC Edgar
Compare AbbVie, Inc. with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes AbbVie, Inc.
Industry : Pharmaceuticals industry performance which includes AbbVie, Inc.